All Ipas instruments, including Ipas MVA Plus® aspirators and Ipas EasyGrip® Cannulae are now distributed by WomanCare Global. Please visit their website for information on their full range of reproductive health care products and how to order them.
Access to basic equipment for safe abortion and postabortion care, as well as emergency interventions, is often lacking in developing countries. Even when health practitioners are well trained, without the right supplies they cannot save women’s lives. Therefore, maintaining a sustainable supply of MVA equipment is necessary in order to be able to fully serve women and meet their needs.
Ipas has developed various tools and guidelines that allow health-care providers to adequately maintain and stock their supplies of MVA instruments. For example, the MVA Calculator estimates active inventory as well as reserve needs and provides guidance on when to reorder, thereby reducing interruptions in patient care due to lack of MVA instruments. In addition, both the MVA Sustainability Workbook and the article “Stocking facilities with MVA according to caseload” will aid providers and health system managers in building a sustainable supply that fits their needs.
The following resources may also be useful:
Ipas's online learning site, IpasU, offers a “stocking facilities” course.
Ipas also provides a MVA Emergency Fund for NGOs. The fund's goal is emergency or short-term bridging supply of MVA in specific contexts where other donor monies are not available. For more information, contact: emergencymva@ipas.org.
In its technical guidelines on safe abortion, the World Health Organization (WHO) states:
Vacuum aspiration and medical abortion are preferred methods for abortion in the first trimester. Both these methods are safe, effective, and suitable for the primary level of care and should also be available at levels of care with greater capacity and in many private clinical settings.
Three methods can be used to safely and effectively terminate pregnancy in the first 12 weeks (84 days) since the woman’s last menstrual period:
- Vacuum aspiration — also called suction abortion, vacuum curettage, suction curettage, menstrual regulation or minisuction — involves removal of the uterine contents by applying suction through a cannula (thin tube) that has been inserted through the cervix. According to the World Health Organization, vacuum aspiration can be used up to 12-15 weeks since the woman’s last menstrual period, depending on the instruments available and the health-care provider’s level of training and skills.
- Medical abortion — also called medication abortion — occurs when pharmacologic agents are administered vaginally or orally to cause expulsion of the uterine contents.
- Sharp curettage — also known as dilatation and curettage (D&C) — involves emptying the uterus by scraping it with curettes (metal instruments). Mechanical dilators are used to open the cervix, and metal curettes are used to scrape the uterine walls. Heavy sedation or general anesthesia is generally required. Because of the elevated risk of complications, the WHO advises that this method should be used only when vacuum aspiration and medication abortion are unavailable (WHO, 2003).
Several methods are used to induce abortion after 12 weeks (84 days) since the woman’s last menstrual period. The two most widely used methods are dilatation and evacuation (D&E) and medication abortion. The World Health Organization lists both methods as appropriate for terminating pregnancies greater than 12 weeks’ duration.
- Dilatation and evacuation (D&E) is a procedure in which the cervix is dilated and the uterine contents are removed using electric vacuum aspiration. D&E abortion is very safe and effective when performed by trained, experienced providers. D&E is an appropriate technique for the second trimester. It is often used in abortions for pregnancies longer than 12 weeks since the woman’s last menstrual period.
- Medical abortion (also called medication abortion) of pregnancies longer than 12 weeks’ duration involves the use of one or more medications to cause uterine contractions that expel the pregnancy, similar to the process of a late miscarriage (spontaneous abortion). Appropriate regimens depend on the duration of the pregnancy and the types of drugs used. Medical-abortion protocols used in early abortion are not appropriate for use after 12 weeks since the women’s last menstrual period. One or more of these drugs is typically used for medication abortion after the first 12 weeks: misoprostol, mifepristone, gemeprost. Medications to induce abortion after 12 weeks are most commonly administered orally or vaginally, although other administration routes are possible. Multiple doses are generally required.
- Åhman, Elisabeth and Iqbal Shah. 2002. Unsafe abortion: Worldwide estimates for 2000. Reproductive Health Matters, 10(19):13-17.
- Bartlett, Linda A., Cynthia J. Berg, Holly B. Shulman, Suzanne B. Zane, Clarice A. Green, Sara Whitehead and Hani K. Atrash. 2004. Risk factors for legal induced abortion-related mortality in the United States. Obstetrics & Gynecology, 103(4):729-737.
- Consensus Statement: Instructions for Use — Abortion Induction with Misoprostol in Pregnancies through 9 Weeks LMP. Expert Meeting on Misoprostol sponsored by Reproductive Health Technologies Project and Gynuity Health Projects. July 28, 2003. Washington, DC.
- Coyteaux, Francine. 2002. Medical abortion: An alternative that increases women’s options. Mujer Saludhable, Bulletin of the Latin American and Caribbean Women’s Health Network, September 2002.
- Early options: A provider's guide to medication abortion. Available online. (Last accessed May 11, 2006.)
- Forna, Fatu and A. Metin Gülmezoglu. 2002. Surgical procedures to evacuate incomplete abortion (Cochrane Review). In The Cochrane Library, Oxford, Update Software.
- Goldberg, Alisa B., Gillian Dean, Mi-Suk Kang, Sarah Youssof and Philip Darney. 2004. Manual versus electric vacuum aspiration for early first-trimester abortion: A controlled study of complication rates. Obstetrics & Gynecology, 103(1):101-7.
- Greenslade, Forrest C., Ann H. Leonard, Janie Benson, Judith Winkler and Victoria L. Henderson. 1993. Manual vacuum aspiration: A summary of clinical and programmatic experience worldwide. Carrboro, NC, IPAS.
- Herrick, Jeannine, Katherine Turner, Teresa McInerney and Laura Castleman. 2004. Woman-centered postabortion care: Reference manual. Chapel Hill, NC, Ipas.
- Hyman, Alyson G. and Laura Castleman. 2005. Woman-centered abortion care: Reference manual. Chapel Hill, NC, Ipas.
- Ipas. 2004. Early abortion with mifepristone and misoprostol. Clinical Practice Notes. Chapel Hill, NC, Ipas.
- Ipas. 2003. Medical abortion: Implications for Africa. Chapel Hill, NC, Ipas.
- Ipas. 2004. Misoprostol alone for first-trimester medical abortion. Clinical Practice Notes. Chapel Hill, NC, Ipas.
- Johnson, Brooke R., Janie Benson, Janet Bradley and Aurora Rábago Ordoñez. 1993. Costs and resource utilization for the treatment of incomplete abortion in Kenya and Mexico. Social Science and Medicine, 36(11):1443-53.
- Magotti, R.F., Phares G.M. Munjinja, Richard S.M. Lema and Edward K.W. Ngwalle. 1995. Cost effectiveness of managing abortions: Manual vacuum aspiration (MVA) compared to evacuation by curettage in Tanzania. East African Medical Journal, 72(4):248-251.
- Planned Parenthood Federation of America. (Last accessed May 11, 2006.)
- World Health Organization (WHO). 2003. Safe abortion: Technical and policy guidance for health systems. Geneva, WHO.

